Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2025)

vTv Therapeutics' Interest & Investment Income history spans 12 years, with the latest figure at $865000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 101.63% year-over-year to $865000.0; the TTM value through Dec 2025 reached $1.9 million, up 19.49%, while the annual FY2025 figure was $1.9 million, 19.49% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $865000.0 at vTv Therapeutics, up from $399000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $865000.0 in Q4 2025 and bottomed at $1000.0 in Q1 2021.
  • The 5-year median for Interest & Investment Income is $152500.0 (2022), against an average of $266250.0.
  • The largest annual shift saw Interest & Investment Income tumbled 91.67% in 2021 before it surged 387.5% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at $1000.0 in 2021, then surged by 15100.0% to $152000.0 in 2022, then plummeted by 42.11% to $88000.0 in 2023, then soared by 387.5% to $429000.0 in 2024, then soared by 101.63% to $865000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Interest & Investment Income are $865000.0 (Q4 2025), $399000.0 (Q3 2025), and $275000.0 (Q2 2025).